Skip to content

Treatment of Foot and Leg Ulcers Using a Laser

Treatment of Foot and Leg Ulcers Using a Laser

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03955289
Enrollment
34
Registered
2019-05-20
Start date
2019-01-15
Completion date
2019-02-01
Last updated
2023-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Foot Ulcer

Brief summary

The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic.

Detailed description

The investigators plan to do a retrospective chart review on patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic starting on May 17, 2018 to November 13, 2018. The investigators chose this date because that is the first time laser treatments were performed in the clinic. The investigators will collect the following data points: * Ulcer etiology * Ulcer location * Prior ulcer treatment type and duration, and wound measurements/characteristics * Wound size 4-6 weeks prior to laser treatment; at treatment time; and then each follow up measurement healed or x weeks * eGFR * Albumin * Last A1c-Presence/absence of DM * Amputation history * Vascular status via ABI's * Identify comorbidities * Identify associated encounters in the patients such as complications (i.e. infection), related readmissions The investigators will identify this information from patient charts (EPIC EMR).

Interventions

None listed

Sponsors

University of Texas Southwestern Medical Center
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* patients who underwent laser treatment for their foot ulcer at the UT Southwestern wound clinic starting on May 17, 2018 to November 13, 2018

Exclusion criteria

* not meeting inclusion criteria

Design outcomes

Primary

MeasureTime frameDescription
Improved healing rate to time to healing4 weeksWounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s). Improved healing rate to time to healing.

Secondary

MeasureTime frameDescription
Decreased complications in diabetic foot ulcers, i.e. infection, hospital admission, amputation4 weeksWounds assessed in this study will show significant improvement in wound characteristics after Erbium-YAG laser debridement(s). Decreased complications in diabetic foot ulcers, i.e. infection, hospital admission, amputation

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026